{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013372","form_type":"8-K","ticker":"BNKK","cik":"0001760903","company_name":"BONK, INC.","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.619469+00:00","generated_at":"2026-05-20T01:48:57.752320+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Safety Shot expands R&D into nootropics and sleep aids leveraging Sure Shot technology","bullets":["Company initiating R&D for nootropic and sleep aid product lines, leveraging Sure Shot technology.","Sure Shot lowers blood alcohol content and boosts clarity, energy, and mood.","Global nootropics market ~$6.5B, projected >$14.9B by 2034 (CAGR 8.7%).","Sleep supplement market $6.8B (2023), projected $11.8B by 2034 (CAGR 5.1%).","Prototypes expected later this year; product release in coming months."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013372","json":"https://secwatch.observer/filing/0001641172-25-013372.json","markdown":"https://secwatch.observer/filing/0001641172-25-013372.md","text":"https://secwatch.observer/filing/0001641172-25-013372.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760903/000164117225013372/0001641172-25-013372-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760903/000164117225013372/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T01:48:57.752320+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}